Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

July 6, 2017

Primary Completion Date

November 6, 2018

Study Completion Date

November 6, 2018

Conditions
Cow Milk Allergy
Interventions
OTHER

Test extensively hydrolyzed formula

extensively hydrolyzed formula with HMOs

OTHER

Control extensively hydrolyzed formula

extensively hydrolyzed formula without HMOs

Trial Locations (12)

10029

Icahn School of Medicine at Mount Sinai, New York

11021

Northwell Health System, Great Neck

29118

Carolina ENT, Orangeburg

38116

Memphis & Shelby County Pediatrics, Memphis

55441

Clinical Research Institute, Plymouth

63141

Midwest Clinical Research, St Louis

71320

Allergy, Asthma and Clinical Research Center, Oklahoma City

76633

Allergy Asthma Research Institute, Waco

77090

Houston Clinical Research Associates, Houston

87109

Breathe America, Albuquerque

92648

Hoag Medical Group, Huntington Beach

94040

Stanford University, Mountain View

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT03236207 - Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula | Biotech Hunter | Biotech Hunter